293b cpd has been researched along with Myocardial Infarction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, A; Becker, R; Freigang, KD; Kraft, P; Kuebler, W; Schoels, W; Senges, JC; Voss, F | 1 |
1 other study(ies) available for 293b cpd and Myocardial Infarction
| Article | Year |
|---|---|
Electrophysiologic effects of the new I(Ks)-blocking agent chromanol 293b in the postinfarction canine heart. Preserved positive use-dependence and preferential prolongation of refractoriness in the infarct zone.
Topics: Animals; Chromans; Dogs; Heart; Myocardial Infarction; Potassium Channel Blockers; Refractory Period, Electrophysiological; Sulfonamides | 2000 |